Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Abnormal cardiac enzymes in systemic sclerosis: a report of four patients and review of the literature.

Vasta B, Flower V, Bucciarelli-Ducci C, Brown S, Korendowych E, McHugh NJ, Pauling JD.

Clin Rheumatol. 2014 Mar;33(3):435-8. doi: 10.1007/s10067-013-2405-1. Epub 2013 Oct 3. Review.

PMID:
24091585
2.

Non-invasive diagnostic and functional evaluation of cardiac and pulmonary involvement in systemic sclerosis.

Sergiacomi G, De Nardo D, Capria A, Manenti G, Fabiano S, Borzi M, De Sanctis G, Konda D, Sperandio M, Schillaci O, Masala S, Simonetti G, Fontana L.

In Vivo. 2004 Mar-Apr;18(2):229-35.

3.

Assessment of myocardial fibrosis and microvascular damage in systemic sclerosis by magnetic resonance imaging and coronary angiotomography.

Rodríguez-Reyna TS, Morelos-Guzman M, Hernández-Reyes P, Montero-Duarte K, Martínez-Reyes C, Reyes-Utrera C, Vazquez-La Madrid J, Morales-Blanhir J, Núñez-Álvarez C, Cabiedes-Contreras J.

Rheumatology (Oxford). 2015 Apr;54(4):647-54. doi: 10.1093/rheumatology/keu350. Epub 2014 Sep 18.

PMID:
25239881
4.

Cardiac complications of systemic sclerosis.

Kahan A, Coghlan G, McLaughlin V.

Rheumatology (Oxford). 2009 Jun;48 Suppl 3:iii45-8. doi: 10.1093/rheumatology/kep110. Review.

PMID:
19487224
5.

Role of N-terminal pro-brain natriuretic peptide in detecting clinically significant cardiac involvement in systemic sclerosis patients.

Chighizola C, Meroni PL, Schreiber BE, Coghlan JG, Denton CP, Ong VH.

Clin Exp Rheumatol. 2012 Mar-Apr;30(2 Suppl 71):S81-5. Epub 2012 May 29.

PMID:
22691215
6.

Cardiac biomarkers in systemic sclerosis: contribution of high-sensitivity cardiac troponin in addition to N-terminal pro-brain natriuretic peptide.

Avouac J, Meune C, Chenevier-Gobeaux C, Borderie D, Lefevre G, Kahan A, Allanore Y.

Arthritis Care Res (Hoboken). 2015 Jul;67(7):1022-30. doi: 10.1002/acr.22547.

7.

Outcome measures for heart involvement in systemic sclerosis.

Allanore Y, Meune C, Kahan A.

Rheumatology (Oxford). 2008 Oct;47 Suppl 5:v51-3. doi: 10.1093/rheumatology/ken268. Review.

PMID:
18784146
8.

Glucocorticoid effects on myocardial performance in patients with systemic sclerosis.

Antoniades L, Sfikakis PP, Mavrikakis M.

Clin Exp Rheumatol. 2001 Jul-Aug;19(4):431-7.

PMID:
11491499
9.

Cardiac magnetic resonance imaging in systemic sclerosis: a cross-sectional observational study of 52 patients.

Hachulla AL, Launay D, Gaxotte V, de Groote P, Lamblin N, Devos P, Hatron PY, Beregi JP, Hachulla E.

Ann Rheum Dis. 2009 Dec;68(12):1878-84. doi: 10.1136/ard.2008.095836. Epub 2008 Dec 3.

10.
11.

Systemic sclerosis. A clinical overview.

Generini S, Fiori G, Moggi Pignone A, Matucci Cerinic M, Cagnoni M.

Adv Exp Med Biol. 1999;455:73-83. Review.

PMID:
10599326
12.

Left heart disease: a frequent cause of early pulmonary hypertension in systemic sclerosis, unrelated to elevated NT-proBNP levels or overt cardiac fibrosis but associated with increased levels of MR-proANP and MR-proADM: retrospective analysis of a French Canadian cohort.

Miller L, Chartrand S, Koenig M, Goulet JR, Rich É, Chin AS, Chartrand-Lefebvre C, Abrahamowicz M, Senécal JL, Grodzicky T.

Scand J Rheumatol. 2014;43(4):314-23. doi: 10.3109/03009742.2013.854407. Epub 2014 Feb 6.

PMID:
25089008
13.

Systemic sclerosis and the heart.

Parks JL, Taylor MH, Parks LP, Silver RM.

Rheum Dis Clin North Am. 2014 Feb;40(1):87-102. doi: 10.1016/j.rdc.2013.10.007. Epub 2013 Nov 7. Review.

PMID:
24268011
14.

High-sensitive troponin-T in adult congenital heart disease.

Eindhoven JA, Roos-Hesselink JW, van den Bosch AE, Kardys I, Cheng JM, Veenis JF, Cuypers JA, Witsenburg M, van Schaik RH, Boersma E.

Int J Cardiol. 2015 Apr 1;184:405-11. doi: 10.1016/j.ijcard.2015.02.027. Epub 2015 Feb 25.

PMID:
25746495
15.

N-terminal pro-brain natriuretic peptide in systemic sclerosis: a new cornerstone of cardiovascular assessment?

Allanore Y, Wahbi K, Borderie D, Weber S, Kahan A, Meune C.

Ann Rheum Dis. 2009 Dec;68(12):1885-9. doi: 10.1136/ard.2008.098087. Epub 2008 Dec 3.

PMID:
19054819
16.

[Heart involvement in systemic sclerosis: analysis of four cases].

Wielosz E, Borys O, Błaszczak P, Majdan M.

Ann Acad Med Stetin. 2012;58(1):33-9; discussion 39. Polish.

PMID:
23547392
17.

Clinical and histopathological features of patients with systemic sclerosis undergoing endomyocardial biopsy.

Mueller KA, Mueller II, Eppler D, Zuern CS, Seizer P, Kramer U, Koetter I, Roecken M, Kandolf R, Gawaz M, Geisler T, Henes JC, Klingel K.

PLoS One. 2015 May 12;10(5):e0126707. doi: 10.1371/journal.pone.0126707. eCollection 2015.

18.

Relation of asymmetric dimethylarginine and cardiac involvement in systemıc sclerosis.

Dağ Ş, Budulgan M, Dilek B, Batmaz I, Arıtürk Z, Nas K, Çevik R.

Acta Reumatol Port. 2014 Jul-Sep;39(3):228-35.

19.

Cardiac involvement in scleroderma.

Deswal A, Follansbee WP.

Rheum Dis Clin North Am. 1996 Nov;22(4):841-60. Review.

PMID:
8923599
20.

[Cardiopathy in systemic sclerosis].

Valentini G, Maione S.

Recenti Prog Med. 1996 Nov;87(11):557-63. Review. Italian.

PMID:
9122540

Supplemental Content

Support Center